March 7, 2023
Alpha-9 Theranostics Strengthens its Scientific Expertise with Key Appointments to Leadership Team and Scientific Advisory Board
Dr. Jutta Wanner to lead R&D discovery efforts and support the...
December 14, 2022
Alpha-9 Theranostics Announces Oversubscribed $75 Million Series B Financing to Advance Portfolio of Radiopharmaceuticals for Cancer
Company is developing bespoke radiopharmaceuticals with capital efficient and rapid approach...
October 13, 2022
Eckert & Ziegler and Alpha-9 Sign Actinium-225 (Ac-225) Reservation Agreement
BOSTON, Mass. and VANCOUVER, British Columbia, October 13, 2022 – Eckert...
October 1, 2022
Alpha-9 Starts Construction of Research Facility in Vancouver
VANCOUVER, British Columbia, October 1, 2022 – Alpha-9 Theranostics, Inc. announced...
May 22, 2022
Isotopia Molecular Imaging and Alpha-9 Theranostics Announce Lutetium-177 Supply Agreement
BOSTON, Mass. and VANCOUVER, British Columbia, May 23, 2022 – Isotopia...
Eckert & Ziegler to Supply Canadian Alpha-9 Theranostics with Lutetium-177 for Clinical Trials
BOSTON, Mass. and VANCOUVER, British Columbia, March 23, 2022 – Eckert...